Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Sep 26;7(3):915–924.e7. doi: 10.1016/j.jaip.2018.09.016

Figure 1.

Figure 1.

(A) Distribution of studies, (B) episode-free days and (C) albuterol inhalations during the study run-in periods (mean ± SEM), and (D) prior year healthcare utilization for wheezing or asthma symptoms in all participants (N=1708) and each latent class (1 = minimal sensitization [N=494], 2 = sensitization with indoor pets [N=409], 3 = sensitization with tobacco smoke exposure [N=452], 4 = multiple sensitization with eczema [N=353]).